Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gross Profit | $10.8B | $11.7B | $12.7B | $14.5B | $16.9B | $17.6B | $20.5B | $23.3B | $24.8B | $11.8B | $11.0B | $11.7B | $11.8B | $15.1B | $17.9B | $18.7B | $19.6B | $24.5B | $24.5B | $22.1B |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Abbott Laboratories's last 12-month Gross Profit is $22.5B, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Abbott Laboratories's Gross Profit growth was 2.6%. The average annual Gross Profit growth rates for Abbott Laboratories have been 2.0% over the past three years, 4.2% over the past five years.
Over the last year, Abbott Laboratories's Gross Profit growth was 2.6%, which is higher than industry growth of 0.0%. It indicates that Abbott Laboratories's Gross Profit growth is Good.